Zobrazeno 1 - 10
of 59
pro vyhledávání: '"David, Paculdo"'
Autor:
Randy E. David, Kelsy Gibson Ferrara, Joshua Schrecker, David Paculdo, Steven Johnson, Rhonda Bentley-Lewis, Rebecca Heltsley, John W. Peabody
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Clinical management of patients with chronic cardiometabolic disease is complicated by polypharmacy. Consequently, when patients clinically deteriorate, physicians are challenged to distinguish both medication nonadherence and dru
Externí odkaz:
https://doaj.org/article/fe40f4cc81ec467da715f599fe3c6ba3
Autor:
John W. Peabody, David Paculdo, Enrico de Belen, Divya Ganesan, Isabella Cooney, Nelson Trujillo
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-10 (2023)
Abstract Background The risk for and treatment of cardiovascular disease (CVD) in type 2 diabetes (T2DM) is often incorrect and delayed. We wished to determine if a novel test improved physicians’ ability to risk stratify, diagnose, and treat patie
Externí odkaz:
https://doaj.org/article/3413469995484fb7bbfaf452c087c100
Autor:
John W Peabody, Divya Ganesan, Czarlota Valdenor, David Paculdo, Joshua Schrecker, Christopher Westerfield, Rebecca Heltsley
Publikováno v:
BMC Primary Care, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Disentangling nonadherence (NA), drug-drug interactions (DDIs), and disease progression from each other is an important clinical challenge for providers caring for patients with cardiometabolic diseases. NAs and DDIs are both ubiq
Externí odkaz:
https://doaj.org/article/9565fe0cb7844aa89f460d1aade8a527
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 13 (2023)
Background Cardiovascular disease risk stratification is necessary and critically important in patients with type 2 diabetes. Despite its known benefits to guide treatment and prevention, we hypothesized that providers do not routinely incorporate th
Externí odkaz:
https://doaj.org/article/af7916e7ec094071a2459110b74c40b9
Autor:
Enrico de Belen, John W. McConnell, Jean M. Elwing, David Paculdo, Ian Cabaluna, Jörg Linder, John W. Peabody
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 2 (2023)
Background Diagnosis of pulmonary hypertension (PH) is often delayed or missed, leading to disease progression and missed treatment opportunities. In this study, we measured variation in care provided by board‐certified cardiologists and pulmonolog
Externí odkaz:
https://doaj.org/article/cad3154eeda147b18bd0b88414a89828
Autor:
Trever Burgon, Linda Casebeer, Holly Aasen, Czarlota Valdenor, Diana Tamondong-Lachica, Enrico de Belen, David Paculdo, John Peabody
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 12, p e31042 (2021)
BackgroundUnwarranted variability in clinical practice is a challenging problem in practice today, leading to poor outcomes for patients and low-value care for providers, payers, and patients. ObjectiveIn this study, we introduced a novel tool, Qual
Externí odkaz:
https://doaj.org/article/c08e055d00c54d6c89aa55957290e933
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 20, Iss , Pp 100224- (2020)
Background: HbA1c is widely used as the standard measure to track glycemic control in patients with diabetes and pre-diabetes but measures average levels of glycated hemoglobin over two to three months, with limited utility in the presence of recent
Externí odkaz:
https://doaj.org/article/22617be7ab20450ca5ffa7a4c8d88663
Autor:
Phil Oravetz, Christopher J White, David Carmouche, Nicole Swan, Josh Donaldson, Russel Ruhl, Czarlota Valdenor, David Paculdo, Mary Tran, John Peabody
Publikováno v:
Open Heart, Vol 6, Iss 1 (2019)
Objective Low quality and unwarranted clinical variation harm patients and increase unnecessary costs. Effective approaches to improve clinical and economic value have been difficult. The Ochsner Health System looked to improve clinical care quality
Externí odkaz:
https://doaj.org/article/95753c2514e1409b9708b19ccb0a0896
Autor:
John Peabody, Joshua Schrecker, Rebecca Heltsley, David Paculdo, Enrico de Belen, Diana Tamondong-Lachica, M. Czarina Acelajado, Othman Ouenes, Trina Kennedy, Elaine Jeter
Publikováno v:
Diagnostics, Vol 11, Iss 7, p 1266 (2021)
Drug–drug interactions (DDIs) are a serious problem in the healthcare system, leading to excess healthcare utilization and costs. We conducted a second prospective randomized, controlled trial to further establish the real-world clinical utility of
Externí odkaz:
https://doaj.org/article/fe976fcbc5db40b4bf348af7e989da2d
Autor:
Czarlota Valdenor, Divya Ganesan, David Paculdo, Joshua Schrecker, Rebecca Heltsley, Christopher Westerfield, John W. Peabody
Publikováno v:
International Journal of Clinical Practice. 2022:1-8
Background. Medication nonadherence in patients with chronic diseases is common, costly, and often underdiagnosed. In the United States, approximately 40–50% of patients with cardiometabolic conditions are not adherent to long-term medications. Dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed788af57c62968c5bbce429e0c2927
https://doi.org/10.1155/2022/6450641
https://doi.org/10.1155/2022/6450641